Idoven, founded in 2018, operates at the intersection of artificial intelligence and cardiology. The company develops AI-powered tools to assist in the detection and diagnosis of cardiovascular diseases, with a focus on early detection and precision medicine. Its technical work spans deep learning, ECG analysis, and cloud computing.
The company's core product is Willem, a cloud-based, CE-marked AI platform designed to analyze electrocardiograms from any device. The platform is engineered to detect 22 specific cardiac patterns and measure four key intervals (P, PR, QT, and QRS duration), supporting clinicians in identifying and triaging patients at scale.
Idoven's AI systems are trained on a substantial dataset comprising over 1.8 million ECG hours from more than 28,500 subjects. The company's research output includes 35 publications in top-tier scientific journals. It was founded by a cardiologist and an engineer with a PhD in AI applied to cardiology, and it maintains partnerships within the Life Sciences and MedTech sectors across Europe.
